DST (May 2022)

Limitation of cytology and the impact on reduction of cervical cancer

  • Daniela da Silva Alves Monteiro,
  • Isabel Cristina Chulvis do Val Guimarães,
  • Susana Cristina Aidé Viviani Fialho,
  • Caroline Alves de Oliveira Martins,
  • Luis Guillermo Coca Velarde,
  • Priscila Loyola Campos,
  • Izabel Cristina dos Santos Teixeira,
  • Julia Sampaio de Souza Morais

DOI
https://doi.org/10.5327/DST-2177-8264-20223405
Journal volume & issue
Vol. 34

Abstract

Read online

Introduction: Cervical cancer is the third most common malignant tumor in the female population and the fourth cause of death from cancer in women in Brazil. The squamocolumnar junction and the transformation zone concentrate 90% of pre-invasive and invasive cervical lesions. Objective: To evaluate the prevalence of cytology without cells of the squamocolumnar junction and feasibility of active search. Methods: Cross-sectional study at a university hospital between 2017 and 2018. The prevalence of cytology without squamocolumnar junction cells was calculated. A convenience sample was obtained and mean age and relationship with presence of transformation zone cells were calculated. An active search was performed and cytology collected, with estrogen preparation if indicated. Medical records of the other women were analyzed. Results: Squamocolumnar junction cells were not found in 28.84% of samples. Mean age was 53 years, without association with presence of squamocolumnar junction cells (p=0.409). Seventy-six women returned, 36 of which (47.37%) used estrogen. Level 2 or 3 cervical intraepithelial neoplasia, microinvasive carcinoma or cancer was not identified. A total of 134 medical records were analyzed; only 36 women (26.87%) completed screening. Conclusions: The presence of squamocolumnar junction cells indicates quality of cytology; the use of es

Keywords